Yipinhong announced that Guangzhou Yipinhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for sertraline hydrochloride oral solution approved and issued by the State Drug Administration. This drug is a class 3 chemical drug. It is treated as having passed the consistency evaluation. The specification is 60ml: 1.2g. The indication is to treat depression-related symptoms and obsessive-compulsive disorder, and can prevent the recurrence of the corresponding symptoms. This approval indicates that the company is qualified to sell the drug in the domestic market, which will enrich the product pipeline and enhance competitiveness in the field of chronic medicine.

Yipinhong announced that Guangzhou Yipinhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for sertraline hydrochloride oral solution approved and issued by the State Drug Administration. This drug is a class 3 chemical drug. It is treated as having passed the consistency evaluation. The specification is 60ml: 1.2g. The indication is to treat depression-related symptoms and obsessive-compulsive disorder, and can prevent the recurrence of the corresponding symptoms. This approval indicates that the company is qualified to sell the drug in the domestic market, which will enrich the product pipeline and enhance competitiveness in the field of chronic medicine.